1 |
Aunins, J. G., Southard, M., Meyers, R. A., Hemmelstein, K. J., and Stella, V. J., Dissolution of carboxylic acids III. The effect of polyionizable buffers. J. Pharm. Sci., 74, 1305-1316 (1985)
DOI
PUBMED
|
2 |
Castillo, J. A., Palomo-Canales, J., Garcia, J. J., Lastres, J. L., Bolas, F., and Torrado, J. J., Preparation and characterization of albendazole -cyclodextrin complexes. Drug Dev. Ind. Pharm., 25, 1241-1248 (1999)
DOI
ScienceOn
|
3 |
FDA, Center for Drug Evaluation and Research. Guidance for Industry - SUPAC-MR: Modified release solid oral dosage forms: Scale-up and postapproval changes: Chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation, September 1997a
|
4 |
Jain, A. C. and Adeyeye, M. C., Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether - cyclodextrins (SBE) and danazol-SBE inclusion complexes. Int. J. Pharm., 212, 177-186 (2001)
DOI
ScienceOn
|
5 |
Serajuddin, A. T. and Rosoff, M., pH-solubility profile of papaverine hydrochloride and its relationship to the dissolution rate of sustained-release pellets. J. Pharm. Sci., 73, 1203-1208 (1984)
DOI
PUBMED
|
6 |
Costa, P. and Lobo, J. M. S., Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev. Ind. Pharm., 27, 811-817 (2001)
DOI
ScienceOn
|
7 |
Langernbucher, F., Linearization of dissolution rate curves by the Weibull distribution. J. Pharm. Pharmacol., 24, 979-981 (1972)
DOI
|
8 |
Qazi, S., Peter Samuel, N. K., Venkatachalam, T. K., and Uckun, F. M., Evaluating dissolution profiles of an anti-HIV agent using ANOVA and non-linear regression models in JMP software. Int. J. Pharm., 252, 27-39 (2003)
DOI
PUBMED
ScienceOn
|
9 |
Dawoodbhai, S. et al., Optimization of tablet formulation talc. Drug Dev. Ind. Pharm., 17, 1343-1371 (1991)
DOI
|
10 |
Abrahamsson, B., Johansson, D., Torstensson, A., and Wingstrand, K., Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine. Pharm. Res., 11, 1093-1097 (1994)
DOI
ScienceOn
|
11 |
Shah, V. P., Konecny, J. J., Everett, R. L., McCullough, B., Noorizadeh, A. C., and Skelly, J. P., In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res., 6, 612-618 (1989)
DOI
ScienceOn
|
12 |
Velasco-De-Paola, M. V. R., Santoro, M. I. R. M., and Gai, M. N., Dissolution kinetics evaluation of controlled-release tablets containing propranolol hydrochloride. Drug Dev. Ind. Pharm., 25, 535-541 (1999)
DOI
ScienceOn
|
13 |
FDA, Center for Drug Evaluation and Research. Guidance for Industry - Extended release oral dosage forms: development, evaluation and application of in vitro/in vivo correlation, September 1997b
|
14 |
Sun, W., Larive, C. K., and Southard, M. Z., A mechanistic study of danazol dissolution in ionic surfactant solutions. J. Pharm. Sci., 92, 424-435 (2003)
DOI
ScienceOn
|
15 |
FDA, Center for Drug Evaluation and Research. Guidance for Industry - Immediate release solid dosage forms: Scale-up and postapproval changes (SUPAC-IR): Chemistry, manufacturing, and controls, in vitro dissolution testing and in vivo bioequivalence test documentation, November, 1995
|
16 |
Crison, J. R., Weiner, N. D., and Amidon, G. L., Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate. J. Pharm. Sci., 86, 384-388 (1997)
DOI
ScienceOn
|
17 |
Chen, L. R., Wesley, J. A., Bhattachar, S., Ruiz, B., Bahash, K., and Babu, S. R., Dissolution behavior of a poorly water soluble compound in the presence of Tween 80. Pharm. Res., 20, 797-801 (2003)
DOI
ScienceOn
|
18 |
Pena Romero, A. et al., Water uptake and force development in an optimized prolonged release formulation. Int. J. Pharm., 73, 239-248 (1991)
DOI
ScienceOn
|
19 |
Riegelman, S. and Collier, P., The application of statistical moment theory to the evaluation of the in vivo dissolution time and absorption time. J. Pharmacokient. Biopharm., 8, 509-534 (1980)
DOI
ScienceOn
|
20 |
Kervinen, L. and Yliruusi, J., Modelling S-shaped dissolution curves. Int. J. Pharm., 92, 115-122 (1993)
DOI
ScienceOn
|